Special 7-Day Tax Relief Sale.
SAVE 15% on ALL Products Every product is on sale for the next 7 days.
(Discount Automatically Given in Shopping Cart)
Coenzyme
Q10 Improves High Blood Pressure
Natt Brignall, N.D.
Healthnotes
Newswire — Coenzyme Q10 (CoQ10) is an effective treatment for people
with a common type of high blood pressure, according to a clinical
trial published in the Southern Medical Journal (2001;94:112–7).
For
this clinical trial, the authors recruited 83 people with a condition
called isolated systolic hypertension (ISH), in which the higher
blood pressure number (systolic) is elevated, but the lower number
(diastolic) is normal. These people were assigned to take either
60 mg of CoQ10 twice daily or a placebo for 12 weeks. Each participant
had their blood pressure checked twice weekly for the entire study.
The
people taking CoQ10 had an 18-point (18 mm Hg) reduction in systolic
blood pressure (from 165 to 147 mm Hg), compared with only a 2-point
decline in the placebo group, a statistically significant difference.
The diastolic blood pressure, which was initially normal, did not
change in either group. A systolic blood pressure reduction of four
points or more was seen in 55% of people taking CoQ10 (those people
were considered responders), whereas 45% of the participants showed
no clinically meaningful reduction in blood pressure. Among the responders,
the average reduction in blood pressure showed a dramatic decline
(25.9 mm Hg). No significant adverse effects were attributed to CoQ10
treatment.
What
is Isolated Systolic Hypertension?
ISH
is the most common type of high blood pressure in the United States.
This type of high blood pressure is particularly common in people
over age 65. People with ISH have a systolic blood pressure of greater
than 140 mm Hg, and a diastolic blood pressure of less than 90 mm
Hg. In a recent clinical trial, reducing systolic blood pressure
in people with ISH by 20 points (a reduction that was easily achieved
by the CoQ10 responders) was associated with a decreased risk of
dying from stroke, heart attack, or heart failure. The survival benefits
were greatest in diabetics with ISH. The new study indicates that
CoQ10 may be a viable alternative to prescription medicines for reducing
blood pressure in some people with ISH. Individuals with high blood
pressure should consult their doctor before taking CoQ10 or changing
their medication regimen.
What
is CoQ10?
CoQ10
is a vitamin-like substance that is necessary for an important step
in the production of energy in the body. CoQ10 is also a potent antioxidant.
The mechanism by which CoQ10 exerts such a dramatic blood pressure-lowering
effect is not currently known.
At
least five other clinical trials have shown a blood pressure-lowering
effect of CoQ10. While most studies have shown a more modest blood
pressure reduction, one other clinical trial found an effect similar
to that seen in the new study. This is the first study to focus specifically
on ISH.
Humans
can synthesize CoQ10, but there may be situations where supplementing
with extra CoQ10 may be beneficial. In particular, people with diabetes
and people on certain cholesterol-lowering medications have been
shown to have low blood levels of CoQ10 compared with the rest of
the population.
Some,
but not all, preliminary clinical trials have shown a significant
difference in absorption between different preparations of CoQ10.
This study used the hydrosoluble form of CoQ10, a form found in one
previous clinical trial to be the most efficiently absorbed in humans.
Author
Profile: Matt Brignall, N.D. is a graduate of the University of
Michigan and Bastyr University. He works at the Seattle Cancer
Treatment and Wellness Center, where he specializes in complementary
medicine approaches to cancer. He has been published in several
journals, including Alternative Medicine Review, Coping With Cancer
and the Journal of the National Cancer Institute. Dr. Brignall
also teaches clinical nutrition at Bastyr University in Kenmore,
WA. He is a regular contributor to Healthnotes, Healthnotes Newswire,
and the Healthnotes Quick! Reference series.